Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Healthtrust
Chinese Patent Office
Citi
Deloitte
Express Scripts
Teva
Johnson and Johnson
Cerilliant

Generated: January 17, 2019

DrugPatentWatch Database Preview

NPLATE Drug Profile

« Back to Dashboard

Summary for Tradename: NPLATE
Patents:18
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for NPLATE

US Patents for NPLATE

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Try a Free Trial LegoChem Biosciences, Inc. (Daejeon, KR) ➤ Try a Free Trial RX search
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Try a Free Trial Astellas Institute for Regenerative Medicine (Marlborough, MA) ➤ Try a Free Trial RX search
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Try a Free Trial LegoChem Biosciences, Inc. (Daejeon, KR) ➤ Try a Free Trial RX search
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Try a Free Trial Astellas Institute for Regenerative Medicine (Marlborough, MA) ➤ Try a Free Trial RX search
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX search
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Try a Free Trial Bayer Intellectual Property GmbH (Monheim, DE) ➤ Try a Free Trial RX search
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for NPLATE

Supplementary Protection Certificates for NPLATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2009006 Lithuania ➤ Try a Free Trial PRODUCT NAME: ROMIPLOSTIMUM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204
25/2009 Austria ➤ Try a Free Trial PRODUCT NAME: ROMIPLOSTIM
2009000039 Germany ➤ Try a Free Trial PRODUCT NAME: ROMIPLOSTIM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204
C/GB09/035 United Kingdom ➤ Try a Free Trial SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB09/035 GRANTED TO KIRIN-AMGEN INC. IN RESPECT OF THE PRODUCT ROMIPLOSTIM, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6361 DATED 20/04/2011 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 05/02/2024.
09/022 Ireland ➤ Try a Free Trial PRODUCT NAME: ROMIPLOSTIM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204
6 Finland ➤ Try a Free Trial
0398 Netherlands ➤ Try a Free Trial 300398, 20191022, EXPIRES: 20240203
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
AstraZeneca
Fuji
Dow
Deloitte
Chinese Patent Office
Johnson and Johnson
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.